Biomind Labs' market value is the price at which a share of Biomind Labs trades on a public exchange. It measures the collective expectations of Biomind Labs investors about its performance. Biomind Labs is trading at 0.11 as of the 27th of January 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.11. With this module, you can estimate the performance of a buy and hold strategy of Biomind Labs and determine expected loss or profit from investing in Biomind Labs over a given investment horizon. Check out Biomind Labs Correlation, Biomind Labs Volatility and Biomind Labs Alpha and Beta module to complement your research on Biomind Labs.
Please note, there is a significant difference between Biomind Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomind Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomind Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Biomind Labs 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biomind Labs' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biomind Labs.
0.00
10/29/2025
No Change 0.00
0.0
In 3 months and 1 day
01/27/2026
0.00
If you would invest 0.00 in Biomind Labs on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding Biomind Labs or generate 0.0% return on investment in Biomind Labs over 90 days. Biomind Labs is related to or competes with Chia Tai, International Stem, Vaccinex, Medigene, and Biora Therapeutics. Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nano... More
Biomind Labs Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biomind Labs' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biomind Labs upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biomind Labs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biomind Labs' standard deviation. In reality, there are many statistical measures that can use Biomind Labs historical prices to predict the future Biomind Labs' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biomind Labs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Biomind Labs is out of control given 3 months investment horizon. Biomind Labs secures Sharpe Ratio (or Efficiency) of 0.14, which signifies that the company had a 0.14 % return per unit of risk over the last 3 months. We were able to break down seventeen different technical indicators, which can help you to evaluate if expected returns of 7.71% are justified by taking the suggested risk. Use Biomind Labs Standard Deviation of 54.56, mean deviation of 13.68, and Risk Adjusted Performance of 0.1057 to evaluate company specific risk that cannot be diversified away. Biomind Labs holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 4.19, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biomind Labs will likely underperform. Use Biomind Labs maximum drawdown, as well as the relationship between the rate of daily change and relative strength index , to analyze future returns on Biomind Labs.
Auto-correlation
0.00
No correlation between past and present
Biomind Labs has no correlation between past and present. Overlapping area represents the amount of predictability between Biomind Labs time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biomind Labs price movement. The serial correlation of 0.0 indicates that just 0.0% of current Biomind Labs price fluctuation can be explain by its past prices.
Other Information on Investing in Biomind Pink Sheet
Biomind Labs financial ratios help investors to determine whether Biomind Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biomind with respect to the benefits of owning Biomind Labs security.